SEC 13F Intelligence

Ikarian Capital, LLC / NVLSEUR

Ikarian Capital, LLC’s Alpine Immune Sciences Inc Position

Does Ikarian Capital, LLC own Alpine Immune Sciences Inc (NVLSEUR)? Not currently — the last reported position was 261.4K shares worth $10M in Q1 2024; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$10M
Q1 2024
Shares
261.4K
% of Portfolio
+1.14%
Quarters Held
8
position exited

Position History NVLSEUR

Reported value by quarter
Q4 ’19: $18,000Q4 ’19Q2 ’20: $46,000Q2 ’20Q3 ’20: $41,000Q3 ’20Q4 ’20: $60,000Q4 ’20Q1 ’21: $3MQ1 ’21Q2 ’21: $3MQ2 ’21Q4 ’23: $9MQ4 ’23Q1 ’24: $10MQ1 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2024261.4K$10M+1.14%
Q4 2023487.2K$9M+0.87%
Q2 2021300.5K$3M+0.22%
Q1 2021304.7K$3M+0.11%
Q4 20204.7K$60,0000.00%
Q3 20204.7K$41,0000.00%
Q2 20204.7K$46,0000.00%
Q4 20194.7K$18,0000.00%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Ikarian Capital, LLC’s full portfolio or all institutional holders of NVLSEUR.